Long-Acting Injectable Preferred for HIV Preexposure Prophylaxis
FRIDAY, Feb. 10, 2023 (HealthDay News) — Long-acting injectable preexposure prophylaxis (PrEP) is the preferred HIV prevention choice for potential male users, according to a study published online Jan. 21 in AIDS and Behavior.Lorraine T. Dean, Sc.D….
Learn MoreCould a Vibrating Pill Ease Chronic Constipation?
THURSDAY, Feb. 9, 2023 (HealthDay News) — A new treatment for chronic constipation may bring relief without having to use drugs. It is a vibrating pill called Vibrant that stimulates the colon as it passes through the body. Although the pill was appr…
Learn MorePegylated Interferon Lambda Effective in Preventing Severe COVID-19
THURSDAY, Feb. 9, 2023 (HealthDay News) — For a predominantly vaccinated adult population with COVID-19, the incidence of hospitalization or emergency department visit is significantly lower for those receiving a single dose of pegylated interferon l…
Learn MoreDifelikefalin Improves Itch Intensity in Notalgia Paresthetica
THURSDAY, Feb. 9, 2023 (HealthDay News) — Oral treatment with difelikefalin results in greater reductions in itch intensity scores than placebo among patients with notalgia paresthetica, but it does not improve secondary outcomes, according to a stud…
Learn MoreASA: Sex Differences Seen in Use of Dual Antiplatelet Therapy After Minor Stroke
THURSDAY, Feb. 9, 2023 (HealthDay News) — Dual antiplatelet therapy (DAPT) is underused following transient ischemic attack (TIA) and minor acute ischemic stroke (AIS), particularly in women, according to a study presented at the annual American Stro…
Learn MoreASA: Sex Differences Seen in Use of Dual Antiplatelet Therapy After Minor Stroke
THURSDAY, Feb. 9, 2023 (HealthDay News) — Dual antiplatelet therapy (DAPT) is underused following transient ischemic attack (TIA) and minor acute ischemic stroke (AIS), particularly in women, according to a study presented at the annual American Stro…
Learn MoreMomelotinib Yields Clinically Significant Improvement in Myelofibrosis
MONDAY, Feb. 6, 2023 (HealthDay News) — Treatment with momelotinib versus danazol yields clinically significant improvements for patients with myelofibrosis, according to a study published online Jan. 28 in The Lancet.Srdan Verstovsek, M.D., from the…
Learn MoreInflation Reduction Act Estimated to Yield Billions in Drug Savings
THURSDAY, Feb. 2, 2023 (HealthDay News) — A new simulation suggests Medicare drug savings from the Inflation Reduction Act of 2022 will be substantial, according to a study published online Jan. 27 in JAMA Health Forum.Benjamin N. Rome, M.D., from Br…
Learn More